ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 80134860304

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860304 and manufactured by manufacturer not specified. The registration is held by GRIFOLS BRASIL LTDA with validity until Dec 11, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.